Aeterna Wealth
Sectoral/Thematic · Direct plan · Growth

Aditya Birla Sun Life Quant Fund (Direct)

Aditya Birla Sun Life Mutual Fund · benchmark Nifty 500 TRI · 2.3 years old · AMFI code 152684

–
Track-record rating

Not rated yet: a rating needs at least 3 years of history (1 year for index funds).

Returns against the index

PeriodFundIndex (TRI)DifferenceRank in category
6 months2.9%2.5%+0.4%2 / 10
1 year3.0%-1.0%+4.0%1 / 10
3 years (a year)––––
5 years (a year)––––

Growth option, point to point to 5 Nov 2026; periods over a year are annualised (CAGR). Index returns use the total-return index, which includes dividends.

Risk

Portfolio

Marico Ltd.4.8%
Torrent Pharmaceuticals Ltd.4.5%
Apollo Hospitals Enterprise Ltd.4.3%
Nestle India Ltd.4.1%
Laurus Labs Ltd.4.0%
Grasim Industries Ltd.4.0%
The Federal Bank Ltd.4.0%
Sun Pharmaceutical Industries Ltd.3.5%
Hindalco Industries Ltd.3.5%
Glenmark Pharmaceuticals Ltd.3.0%

Top 10 holdings, September 2026 portfolio.

Common questions

What is the NAV of Aditya Birla Sun Life Quant Fund (Direct plan)?

₹10.35 on 5 Nov 2026 (Growth option).

What is the expense ratio of Aditya Birla Sun Life Quant Fund (Direct)?

1.26% a year; the Regular plan's is 2.53%.

What does Aditya Birla Sun Life Quant Fund invest in?

Its largest holdings are Marico Ltd., Torrent Pharmaceuticals Ltd., Apollo Hospitals Enterprise Ltd., with 44 stocks in all (September 2026 portfolio).

Data as of 5 Nov 2026: NAVs from AMFI, index data from NSE Indices, portfolios from Aditya Birla Sun Life Mutual Fund's monthly disclosure. Updated every weekday. Read the scheme documents before investing.